Amarin secures $100M, hiring sales force for Vascepa

Amarin Corp. plc (NASDAQ:AMRN) said it secured $100 million in debt from Pharmakon Advisors and plans to hire a 250-300 personnel sales force to launch hypertriglyceridemia drug Vascepa icosapent ethyl next quarter. On a conference call, Amarin said the hiring of a sales force does not affect the company's commercialization strategy, which includes three potential paths: an acquisition of the company, a partnership or self-commercialization. Amarin, which made the announcements after market close, was down $0.09 to $11.95 on Thursday. The stock fell $2.20 (18%) to $9.75 in early after-hours trading. ...